Clinical Study

Dynamic Metabolic Changes during the First 3 Months after 90Y-Ibritumomab Tiuxetan Radioimmunotherapy

Figure 3

Average percent decrease in relative to baseline values as a function of time after RIT. Error bars represent standard deviations, with negative error bars on the -axis omitted.
368947.fig.003